| pubmed-article:9449022 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9449022 | lifeskim:mentions | umls-concept:C0002658 | lld:lifeskim |
| pubmed-article:9449022 | lifeskim:mentions | umls-concept:C1533685 | lld:lifeskim |
| pubmed-article:9449022 | lifeskim:mentions | umls-concept:C0013153 | lld:lifeskim |
| pubmed-article:9449022 | lifeskim:mentions | umls-concept:C0679970 | lld:lifeskim |
| pubmed-article:9449022 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9449022 | pubmed:dateCreated | 1998-5-4 | lld:pubmed |
| pubmed-article:9449022 | pubmed:abstractText | Six hundred and thirty four interviews of injecting drug users were performed between 1992 and 1994 as part of a study of injecting drug use and HIV prevalence in Edinburgh, Scotland. Amphetamine was injected by more subjects (44%) than any other drug. Preference for injection as the route of administration of amphetamine increased over the period despite no change in the popularity of the drug generally. Simultaneously, heroin use and injection declined. Analyses indicated that amphetamine injectors comprised two distinct sub-groups. The majority were polydrug injectors who injected frequently, had a longer injecting history and were more likely to share injection equipment. About one-fifth were stimulant-only injectors who injected infrequently, were relatively recent initiates to injecting and whose numbers increased over the 3 years. Drug treatment and prevention services may need to explore alternative methods to respond effectively to these emerging trends. | lld:pubmed |
| pubmed-article:9449022 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9449022 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9449022 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9449022 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9449022 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:9449022 | pubmed:issn | 0376-8716 | lld:pubmed |
| pubmed-article:9449022 | pubmed:author | pubmed-author:RichardsonAA | lld:pubmed |
| pubmed-article:9449022 | pubmed:author | pubmed-author:DaviesTT | lld:pubmed |
| pubmed-article:9449022 | pubmed:author | pubmed-author:PetersAA | lld:pubmed |
| pubmed-article:9449022 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9449022 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:9449022 | pubmed:volume | 48 | lld:pubmed |
| pubmed-article:9449022 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9449022 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9449022 | pubmed:pagination | 227-34 | lld:pubmed |
| pubmed-article:9449022 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:meshHeading | pubmed-meshheading:9449022-... | lld:pubmed |
| pubmed-article:9449022 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9449022 | pubmed:articleTitle | Increasing popularity of injection as the route of administration of amphetamine in Edinburgh. | lld:pubmed |
| pubmed-article:9449022 | pubmed:affiliation | Centre for HIV/AIDS and Drug Studies, City Hospital, Edinburgh, Scotland, UK. | lld:pubmed |
| pubmed-article:9449022 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9449022 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
